Farwell Wildon
SEC CIK 1847941 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | Chief Medical Off | 143.5K | — | $955.5K | 20 | 2021-12-10 | 2024-08-19 |
Most active insiders at DYN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Rhodes Jason P | Dir | — | $129.10M |
| 2 | Kersten Dirk | Dir | — | $38.57M |
| 3 | Cox John | CEO, Pres, Dir | — | $443.7K |
| 4 | Posner Brian S | Dir | $274.8K | — |
| 5 | Kerr Douglas | Chief Medical Off | — | $233.1K |
| 6 | Lucera Erick | CFO | — | $228.7K |
| 7 | Friedl-Naderer Johanna | Chief Commercial Off | — | $43.4K |
| 8 | Lubner David Charles | Dir | — | — |
Farwell Wildon made no open-market trades at DYN in the last 12 months.
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2024-08-20 | 2024-08-19 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $45.12 | -2,321 | 143.5K | -2% | -$104.7K |
| MT | 2024-06-11 | 2024-06-11 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $31.27 | -2,636 | 146.6K | -2% | -$82.4K |
| MT | 2024-05-17 | 2024-05-16 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $28.27 | -2,381 | 148.2K | -2% | -$67.3K |
| MT | 2024-03-12 | 2024-03-11+ | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $25.65 | -2,615 | 151.6K | -2% | -$67.1K |
| MT | 2024-03-11 | 2024-03-07 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $25.86 | -9,921 | 154.7K | -6% | -$256.6K |
| T | 2024-02-28 | 2024-02-28 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $25.00 | -407 | 163.1K | -0.2% | -$10.2K |
| T | 2024-02-14 | 2024-02-12 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $25.07 | -5,493 | 163.5K | -3% | -$137.7K |
| T | 2024-01-26 | 2024-01-26 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $25.00 | -100 | 169.0K | -0.1% | -$2,500 |
| M | 2023-12-12 | 2023-12-11+ | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $10.66 | -2,666 | 169.1K | -2% | -$28.4K |
| D | 2023-11-16 | 2023-11-15 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | A - Grant | $0.00 | +82.5K | 171.8K | +92% | $0 |
| 2023-09-13 | 2023-09-12 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $10.41 | -1,707 | 89.2K | -2% | -$17.8K | |
| 2023-06-14 | 2023-06-13 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $12.43 | -1,698 | 91.0K | -2% | -$21.1K | |
| 2023-03-15 | 2023-03-14 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $13.33 | -7,441 | 92.7K | -7% | -$99.2K | |
| D | 2022-12-13 | 2022-12-12 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $10.87 | -628 | 100.1K | -0.6% | -$6,826 |
| D | 2022-12-13 | 2022-12-09 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | A - Grant | $0.00 | +36.0K | 100.7K | +56% | $0 |
| 2022-09-15 | 2022-09-15 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | D - Sale to Iss | $14.05 | -658 | 64.7K | -1% | -$9,245 | |
| 2022-06-15 | 2022-06-14 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | D - Sale to Iss | $4.95 | -668 | 65.4K | -1% | -$3,307 | |
| 2022-03-14 | 2022-03-11 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $8.73 | -640 | 66.0K | -1.0% | -$5,587 | |
| 2022-03-03 | 2022-03-02 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | S - Sale | $8.56 | -5,617 | 66.7K | -8% | -$48.1K | |
| D | 2021-12-14 | 2021-12-10 | DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Off | A - Grant | $0.00 | +22.3K | 72.3K | +45% | $0 |
Purchase Sale Sale after option exercise All abbreviations